ClinicalTrials.Veeva

Menu

Identification of New Inborn Errors of Immunity

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Enrolling

Conditions

Primary Immune Deficiency Disorder

Treatments

Diagnostic Test: Diagnostic Test

Study type

Observational

Funder types

Other

Identifiers

NCT03414528
Ident_PID

Details and patient eligibility

About

Analysis of DNA samples of patients with molecularly undetermined PID by whole exome/genome sequencing.

Transcriptome analysis of patients with molecularly undetermined PID.

Enrollment

300 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with primary immunodeficiency (PID)
  • Male and Female participants 0 years to adult age (any)
  • Written informed consent by the participant after information about the research project

Exclusion criteria

  • Secondary immunodeficiency
  • Refusal to enter the study

Trial design

300 participants in 1 patient group

Patients with PID
Treatment:
Diagnostic Test: Diagnostic Test

Trial contacts and locations

1

Loading...

Central trial contact

Ulrich Siler, PD Dr.; Janine Reichenbach, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems